Titratable Dosing in Moderate to Severe Asthmatics

NCT00651768 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

570

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: budesonide/formoterol
DRUG: Symbicort pMDI + budesonide HFA pMDI

Sponsor

AstraZeneca